| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR6B1 VIPR1 OR4D10 OR52D1 GPR173 OR52L1 MC2R GLRA3 SCTR OR5K2 ROS1 GPR183 OR2L13 OR14A16 OR1L1 PRLR TMEM63A | 7.46e-05 | 1353 | 88 | 17 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR6B1 VIPR1 OR4D10 OR52D1 GPR173 OR52L1 MC2R SCTR OR5K2 GPR183 OR2L13 OR14A16 OR1L1 | 1.27e-04 | 884 | 88 | 13 | GO:0004930 |
| GeneOntologyMolecularFunction | GTPase activator activity | 2.33e-04 | 279 | 88 | 7 | GO:0005096 | |
| GeneOntologyMolecularFunction | L-leucine binding | 3.97e-04 | 7 | 88 | 2 | GO:0070728 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 6.29e-04 | 431 | 88 | 8 | GO:0004984 | |
| Domain | GPCR_2_VIP_rcpt_1 | 6.27e-05 | 3 | 86 | 2 | IPR001771 | |
| Domain | ARM-type_fold | 1.68e-04 | 339 | 86 | 8 | IPR016024 | |
| Domain | GPCR_Rhodpsn_7TM | OR6B1 OR4D10 OR52D1 GPR173 OR52L1 MC2R OR5K2 GPR183 OR2L13 OR14A16 OR1L1 | 2.47e-04 | 670 | 86 | 11 | IPR017452 |
| Domain | 7tm_1 | OR6B1 OR4D10 OR52D1 GPR173 OR52L1 MC2R OR5K2 GPR183 OR2L13 OR14A16 OR1L1 | 2.70e-04 | 677 | 86 | 11 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR6B1 OR4D10 OR52D1 GPR173 OR52L1 MC2R OR5K2 GPR183 OR2L13 OR14A16 OR1L1 | 2.99e-04 | 685 | 86 | 11 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR6B1 OR4D10 OR52D1 GPR173 OR52L1 MC2R OR5K2 GPR183 OR2L13 OR14A16 OR1L1 | 3.22e-04 | 691 | 86 | 11 | PS50262 |
| Domain | GPCR_Rhodpsn | OR6B1 OR4D10 OR52D1 GPR173 OR52L1 MC2R OR5K2 GPR183 OR2L13 OR14A16 OR1L1 | 3.26e-04 | 692 | 86 | 11 | IPR000276 |
| Domain | Olfact_rcpt | 4.54e-04 | 393 | 86 | 8 | IPR000725 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 11937265 | ||
| Pubmed | Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. | 1.57e-08 | 3 | 88 | 3 | 9560339 | |
| Pubmed | Analysis of Ikaros family splicing variants in human hematopoietic lineages. | 1.57e-08 | 3 | 88 | 3 | 20432734 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 27502439 | ||
| Pubmed | Aberrant Ikaros, Aiolos, and Helios expression in Hodgkin and non-Hodgkin lymphoma. | 1.57e-08 | 3 | 88 | 3 | 18332232 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCSK5 RHPN1 FLNA ZBED4 PCNX4 NISCH MAP3K11 RIC8A WDR90 RALGAPA2 DOCK6 FEM1A AP3D1 MED12 TBCD ANKRD16 | 1.64e-08 | 1105 | 88 | 16 | 35748872 |
| Pubmed | Eos and pegasus, two members of the Ikaros family of proteins with distinct DNA binding activities. | 1.56e-07 | 5 | 88 | 3 | 10978333 | |
| Pubmed | A molecular dissection of the repression circuitry of Ikaros. | 5.58e-06 | 14 | 88 | 3 | 12015313 | |
| Pubmed | Helios deficiency has minimal impact on T cell development and function. | 6.33e-06 | 2 | 88 | 2 | 19620299 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 31558666 | ||
| Pubmed | A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS. | 6.33e-06 | 2 | 88 | 2 | 34155405 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 24509510 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 33499314 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 25512366 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 11173542 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 9155026 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 31151137 | ||
| Pubmed | Impaired tissue homing by the Ikzf3N159S variant is mediated by interfering with Ikaros function. | 6.33e-06 | 2 | 88 | 2 | 37662955 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 33182226 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 11812772 | ||
| Pubmed | Critical function of Ikaros in controlling Aiolos gene expression. | 6.33e-06 | 2 | 88 | 2 | 17383641 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 27881177 | ||
| Pubmed | Predominant interaction of both Ikaros and Helios with the NuRD complex in immature thymocytes. | 6.33e-06 | 2 | 88 | 2 | 17681952 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 22931634 | ||
| Pubmed | Ikaros promotes early-born neuronal fates in the cerebral cortex. | 1.47e-05 | 19 | 88 | 3 | 23382203 | |
| Pubmed | 1.73e-05 | 20 | 88 | 3 | 24082127 | ||
| Pubmed | 1.83e-05 | 322 | 88 | 7 | 26514267 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 19520869 | ||
| Pubmed | The genomic landscape of hypodiploid acute lymphoblastic leukemia. | 1.90e-05 | 3 | 88 | 2 | 23334668 | |
| Pubmed | Co-stimulation of murine CD4 T cell growth: cooperation between B7 and heat-stable antigen. | 1.90e-05 | 3 | 88 | 2 | 1385153 | |
| Pubmed | CADPS2 gene expression is oppositely regulated by LRRK2 and alpha-synuclein. | 1.90e-05 | 3 | 88 | 2 | 28647363 | |
| Pubmed | Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor. | 1.90e-05 | 3 | 88 | 2 | 8390245 | |
| Pubmed | The CD8alpha gene locus is regulated by the Ikaros family of proteins. | 1.90e-05 | 3 | 88 | 2 | 12504015 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ABCC1 FLNA ATP6V0A1 NISCH RAB3GAP2 DNAH2 CSTF3 RIC8A POMK STT3A TBCD | 2.60e-05 | 942 | 88 | 11 | 31073040 |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 25446972 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 24328678 | ||
| Pubmed | DPP9 is a novel component of the N-end rule pathway targeting the tyrosine kinase Syk. | 3.79e-05 | 4 | 88 | 2 | 27614019 | |
| Pubmed | The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. | 3.79e-05 | 4 | 88 | 2 | 24292623 | |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 28355569 | ||
| Pubmed | ATP6V0A1 CD80 RAB3GAP2 LRRK2 NEK7 ZNF224 ZNF225 RALGAPA2 SEMA3E | 6.12e-05 | 686 | 88 | 9 | 29987050 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 23246582 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 10766745 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 UBR2 VIPR1 PTPN13 DPP9 PCNX4 RPS6KB1 CSTF3 DOCK6 SESN1 STT3A TBCD TMEM63A | 9.30e-05 | 1489 | 88 | 13 | 28611215 |
| Pubmed | 9.43e-05 | 6 | 88 | 2 | 14709557 | ||
| Pubmed | 9.43e-05 | 6 | 88 | 2 | 15024086 | ||
| Pubmed | Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression. | 9.43e-05 | 6 | 88 | 2 | 20566697 | |
| Pubmed | 1.24e-04 | 38 | 88 | 3 | 19574343 | ||
| Pubmed | 1.25e-04 | 754 | 88 | 9 | 35906200 | ||
| Pubmed | Aiolos collaborates with Blimp-1 to regulate the survival of multiple myeloma cells. | 1.32e-04 | 7 | 88 | 2 | 26823144 | |
| Pubmed | Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. | 1.32e-04 | 7 | 88 | 2 | 10357820 | |
| Pubmed | 1.51e-04 | 105 | 88 | 4 | 24667918 | ||
| Pubmed | 2.25e-04 | 9 | 88 | 2 | 22142223 | ||
| Pubmed | 2.25e-04 | 9 | 88 | 2 | 19734904 | ||
| Pubmed | Myh7b/miR-499 gene expression is transcriptionally regulated by MRFs and Eos. | 2.25e-04 | 9 | 88 | 2 | 22638570 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 2.31e-04 | 340 | 88 | 6 | 11875048 | |
| Pubmed | 2.31e-04 | 340 | 88 | 6 | 11802173 | ||
| Pubmed | Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. | 2.38e-04 | 342 | 88 | 6 | 23128233 | |
| Pubmed | 2.42e-04 | 343 | 88 | 6 | 32295537 | ||
| Pubmed | 2.54e-04 | 346 | 88 | 6 | 14611657 | ||
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 2.63e-04 | 223 | 88 | 5 | 33187986 | |
| Pubmed | 2.81e-04 | 10 | 88 | 2 | 15809305 | ||
| Pubmed | 2.81e-04 | 10 | 88 | 2 | 15670850 | ||
| Pubmed | 3.31e-04 | 129 | 88 | 4 | 23022380 | ||
| Pubmed | Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. | 3.43e-04 | 11 | 88 | 2 | 10204490 | |
| Pubmed | 3.43e-04 | 11 | 88 | 2 | 23000144 | ||
| Pubmed | 3.43e-04 | 11 | 88 | 2 | 23981064 | ||
| Pubmed | Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. | 3.43e-04 | 11 | 88 | 2 | 11500364 | |
| Pubmed | 4.54e-04 | 541 | 88 | 7 | 14983052 | ||
| Pubmed | Ikaros confers early temporal competence to mouse retinal progenitor cells. | 4.85e-04 | 13 | 88 | 2 | 18940586 | |
| Pubmed | 5.07e-04 | 61 | 88 | 3 | 20634197 | ||
| Pubmed | 5.31e-04 | 62 | 88 | 3 | 23088713 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | 5.60e-04 | 925 | 88 | 9 | 28986522 | |
| Pubmed | κB-Ras proteins regulate both NF-κB-dependent inflammation and Ral-dependent proliferation. | 5.65e-04 | 14 | 88 | 2 | 25220458 | |
| Pubmed | 6.51e-04 | 15 | 88 | 2 | 31552487 | ||
| Pubmed | 7.42e-04 | 16 | 88 | 2 | 18824598 | ||
| Pubmed | RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation. | 7.42e-04 | 16 | 88 | 2 | 30760870 | |
| Pubmed | 7.58e-04 | 70 | 88 | 3 | 12036966 | ||
| Pubmed | 8.40e-04 | 17 | 88 | 2 | 15767674 | ||
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | 1.05e-03 | 454 | 88 | 6 | 33226137 | |
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 1.08e-03 | 79 | 88 | 3 | 12679517 | |
| Pubmed | STAGA recruits Mediator to the MYC oncoprotein to stimulate transcription and cell proliferation. | 1.17e-03 | 20 | 88 | 2 | 17967894 | |
| Pubmed | 1.17e-03 | 20 | 88 | 2 | 12743021 | ||
| Pubmed | 1.29e-03 | 21 | 88 | 2 | 36332009 | ||
| Pubmed | CECR2 is involved in spermatogenesis and forms a complex with SNF2H in the testis. | 1.29e-03 | 21 | 88 | 2 | 22154806 | |
| Pubmed | RALGAPA1 PTPN13 ATP6V0A1 DPP9 NISCH RAB3GAP2 BAZ1B EEF2K BCKDHA AP3D1 STT3A | 1.31e-03 | 1487 | 88 | 11 | 33957083 | |
| Pubmed | 1.33e-03 | 85 | 88 | 3 | 15449545 | ||
| Pubmed | 1.41e-03 | 22 | 88 | 2 | 15767678 | ||
| Pubmed | Essential and supporting host cell factors for HIV-1 budding. | 1.55e-03 | 23 | 88 | 2 | 22004035 | |
| Pubmed | 1.79e-03 | 504 | 88 | 6 | 34432599 | ||
| Pubmed | The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function. | 1.83e-03 | 25 | 88 | 2 | 19240132 | |
| Pubmed | Family-based analysis of candidate genes for polycystic ovary syndrome. | 2.13e-03 | 27 | 88 | 2 | 20200332 | |
| Pubmed | 2.15e-03 | 708 | 88 | 7 | 39231216 | ||
| Pubmed | 2.24e-03 | 102 | 88 | 3 | 9734811 | ||
| Pubmed | 2.29e-03 | 28 | 88 | 2 | 12471243 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.37e-03 | 104 | 88 | 3 | 31240132 | |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN | 4.73e-06 | 200 | 87 | 7 | M4667 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.58e-07 | 146 | 88 | 6 | deeb2c90a478deac7805e1f0d1466bf5bc42f746 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-06 | 177 | 88 | 6 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.88e-06 | 186 | 88 | 6 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-05 | 168 | 88 | 5 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 173 | 88 | 5 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.68e-05 | 177 | 88 | 5 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.68e-05 | 177 | 88 | 5 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.68e-05 | 177 | 88 | 5 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.83e-05 | 179 | 88 | 5 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.90e-05 | 180 | 88 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.98e-05 | 181 | 88 | 5 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 182 | 88 | 5 | 0f06309318c064f0ebdb12a46226b90032290137 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.14e-05 | 183 | 88 | 5 | ffa831f67ed005f05d1b80ebc707e046fc08e22f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.14e-05 | 183 | 88 | 5 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 3.14e-05 | 183 | 88 | 5 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 3.22e-05 | 184 | 88 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.22e-05 | 184 | 88 | 5 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 3.31e-05 | 185 | 88 | 5 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-05 | 185 | 88 | 5 | d42f6722a6771752cd744146a09e2ead9b7252bc | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 3.40e-05 | 186 | 88 | 5 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 3.48e-05 | 187 | 88 | 5 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 3.57e-05 | 188 | 88 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 3.66e-05 | 189 | 88 | 5 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.76e-05 | 190 | 88 | 5 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.85e-05 | 191 | 88 | 5 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.85e-05 | 191 | 88 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-Th17|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-05 | 191 | 88 | 5 | b3ed4797a7a9810cf3507e0d0f23f45c35bd8ba2 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 3.95e-05 | 192 | 88 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.95e-05 | 192 | 88 | 5 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.05e-05 | 193 | 88 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 4.05e-05 | 193 | 88 | 5 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.05e-05 | 193 | 88 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 4.25e-05 | 195 | 88 | 5 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.36e-05 | 196 | 88 | 5 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.36e-05 | 196 | 88 | 5 | e8c4eeb4b6c6d9bccca2adb942d4cfbaab39636c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.46e-05 | 197 | 88 | 5 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.57e-05 | 198 | 88 | 5 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | COVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.57e-05 | 198 | 88 | 5 | 45419f2804b4be79bae6632e71c54e1af482d115 | |
| ToppCell | ASK428-Epithelial-Type_2|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.57e-05 | 198 | 88 | 5 | ec0d1801363adb70c6a26655b79d12b438c7417d | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.57e-05 | 198 | 88 | 5 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.57e-05 | 198 | 88 | 5 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 4.57e-05 | 198 | 88 | 5 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-05 | 119 | 88 | 4 | aa3860c8d25c85baa79a0b6637bce2e269adfcc2 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-04 | 139 | 88 | 4 | f1d1a51a79afdddc82e73cd29b3240e3e973db28 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-04 | 139 | 88 | 4 | ecc2a6ecc27748c50885cd4f0ad8a8cd1252aee6 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-04 | 146 | 88 | 4 | b76110b159acd27a2c8d6a9f98336608ace1ec12 | |
| ToppCell | Control-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.12e-04 | 148 | 88 | 4 | 662c057030effc9eb61216e81d3967e6983c244f | |
| ToppCell | P28-Hematopoietic-Immune-immune_cell_unspecified|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.65e-04 | 157 | 88 | 4 | a70f93aff07b6b7a9efce33b12b024116648dc0a | |
| ToppCell | P28-Hematopoietic-Immune|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.65e-04 | 157 | 88 | 4 | b1f520b1e0ea7abb19d0dd27021eafbea0fd90cd | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-04 | 161 | 88 | 4 | 140b3c7077947c541cff54f6754e2df968345f4d | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-04 | 161 | 88 | 4 | 78cb72c462167021195917a06052bcdc367ad890 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.92e-04 | 161 | 88 | 4 | d72c572613f8eff3251cb7b1e9dcc76d193b2f21 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-04 | 161 | 88 | 4 | 06e7becfd11d6ef1a45a9cfdfcb40b812600038e | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.98e-04 | 162 | 88 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-04 | 162 | 88 | 4 | 0321fc954ae4ad67ca438cbbc84632562d222188 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-04 | 162 | 88 | 4 | 16f9fbcaa0093ffc5a2a5e32db6040e2cb519d47 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-04 | 162 | 88 | 4 | 5731f9514434296132df4bc86f78ce87b07cdeca | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-leukocyte|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 163 | 88 | 4 | 2f32a9ab0230fdca98ffa7fd59397301d50e4f30 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 163 | 88 | 4 | 6c2967dee563295febe2adabf503d095cb911ccf | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.13e-04 | 164 | 88 | 4 | 74bf6080abd9191e3db8ee892fce84f1dcc4b775 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.20e-04 | 165 | 88 | 4 | e381bcd558745f3a60346f78b49d0b2672184baa | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 165 | 88 | 4 | 0c80abf13409767825ef8a507b498afafa7e89c5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.20e-04 | 165 | 88 | 4 | fee7f2f8d0e25c0d067adc73f8913721bd709a3e | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 165 | 88 | 4 | 66f0364098d82629aa2ec1dfe0c5ad23de7c2c12 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 165 | 88 | 4 | cced77f2d74b07010307d7f4788b8cf3fdaeb91a | |
| ToppCell | Mild/Remission-B_memory-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.27e-04 | 166 | 88 | 4 | 03e1a369d8a83b814def07e29cabb023226b4828 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 166 | 88 | 4 | e01c720de6d4ca144c55378e023e718a64bf32f6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.27e-04 | 166 | 88 | 4 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.27e-04 | 166 | 88 | 4 | 739dfbe927f409821ff23aca6e47ebe78f57e859 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.35e-04 | 167 | 88 | 4 | a6ff7a3d9b80839c0efa91658836812e868561fa | |
| ToppCell | Severe-B_memory-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.43e-04 | 168 | 88 | 4 | 85a36e1b994a8fd2f589563f011913e4944dc1cd | |
| ToppCell | droplet-Fat-Scat-21m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 168 | 88 | 4 | 99343f7a76ff70a2252c365d527f9c8ae16b8571 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.43e-04 | 168 | 88 | 4 | ca94b29c1030484143a77f2df06dad74d2c6136e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-04 | 168 | 88 | 4 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.50e-04 | 169 | 88 | 4 | ccb7b2daa65cb5f4c1e7a48b3bcdf0cb8f7675c3 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.66e-04 | 171 | 88 | 4 | 87cb65648c663e246f94cea1a5ed12e8e29ec629 | |
| ToppCell | droplet-Trachea-nan-3m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 172 | 88 | 4 | f6c00a6a7e81aaf96c55eb3a3c88e3719f102ea0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.75e-04 | 172 | 88 | 4 | adc09c4d1b63fe84150516beb692db1e7f7ac980 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-tracheal_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.75e-04 | 172 | 88 | 4 | f3bbe3f069ad070778430d1a6cd9db0a76deb8de | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-04 | 172 | 88 | 4 | 94093d356b0252b440deda4e1b0ac332b31513f6 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.83e-04 | 173 | 88 | 4 | fde1fabb8d13d05998ac3f21ecb1fde6a7a2f337 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-04 | 173 | 88 | 4 | 6e92983d9f8a2a37f23e60a0d5bb1738217897bc | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.83e-04 | 173 | 88 | 4 | dcde3252ff96448d3a61039a4948c74ad321a218 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-04 | 173 | 88 | 4 | 4c788c1dad1da495b3b5c10f95e779848dfe85dc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.91e-04 | 174 | 88 | 4 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.91e-04 | 174 | 88 | 4 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.91e-04 | 174 | 88 | 4 | 61aa89b56ebda0eba1ba675d5f036992967f670f | |
| ToppCell | wk_15-18-Hematologic-Myeloid-aDC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.00e-04 | 175 | 88 | 4 | c31178d7a5a19d7afd336c9ec0e5c493655a6aa4 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-04 | 175 | 88 | 4 | 98cb577df466700e72d1bbc6689205ccf2e7fcba | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.08e-04 | 176 | 88 | 4 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-04 | 177 | 88 | 4 | ffc4c675b25ffe8bd3441ce26dd0984fef4b3b88 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.17e-04 | 177 | 88 | 4 | f28243b51be104cb3adcde63f03fc2206ed3121e | |
| ToppCell | Mild/Remission-B_memory-6|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.17e-04 | 177 | 88 | 4 | 8f2ce5ffc94ca90412cb6899629f322dc778215c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.17e-04 | 177 | 88 | 4 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.26e-04 | 178 | 88 | 4 | 8184a2b9872f7ca12a9823535de485e841aeffb1 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.35e-04 | 179 | 88 | 4 | de3ddc1264e43727be50d69b81cc84a3c91812a2 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 4.35e-04 | 179 | 88 | 4 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.35e-04 | 179 | 88 | 4 | def981e97e3ff9019910c9af3861ca0d08eb0d0f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.35e-04 | 179 | 88 | 4 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.35e-04 | 179 | 88 | 4 | 9fc44637c9a7551fd47b8533e45a9c199e164a95 | |
| Drug | mV GABA | 1.11e-06 | 6 | 88 | 3 | CID000128435 | |
| Disease | FG syndrome (is_implicated_in) | 2.46e-05 | 3 | 85 | 2 | DOID:14711 (is_implicated_in) | |
| Disease | FG SYNDROME 4 (disorder) | 2.46e-05 | 3 | 85 | 2 | C1845546 | |
| Disease | FG SYNDROME 2 | 2.46e-05 | 3 | 85 | 2 | C1845902 | |
| Disease | FG SYNDROME 3 | 2.46e-05 | 3 | 85 | 2 | C1845567 | |
| Disease | FG syndrome | 2.46e-05 | 3 | 85 | 2 | C0220769 | |
| Disease | FG syndrome | 4.90e-05 | 4 | 85 | 2 | cv:C0220769 | |
| Disease | Phyllodes Tumor | 8.15e-05 | 5 | 85 | 2 | C0010701 | |
| Disease | Malignant Cystosarcoma Phyllodes | 8.15e-05 | 5 | 85 | 2 | C0600066 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 4.10e-04 | 50 | 85 | 3 | C0023453 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 4.60e-04 | 52 | 85 | 3 | C0023452 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 7.36e-04 | 61 | 85 | 3 | C1961102 | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 8.40e-04 | 15 | 85 | 2 | C2930967 | |
| Disease | inflammatory bowel disease | 1.91e-03 | 449 | 85 | 6 | EFO_0003767 | |
| Disease | lung adenocarcinoma (is_marker_for) | 1.92e-03 | 85 | 85 | 3 | DOID:3910 (is_marker_for) | |
| Disease | Ovarian Serous Adenocarcinoma | 1.99e-03 | 23 | 85 | 2 | C1335177 | |
| Disease | CFTR mutation carrier status | 2.36e-03 | 25 | 85 | 2 | EFO_0021794 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HEAASMGHRDCVRYL | 76 | Q6P6B7 | |
| EYSTEHHLVCRMLLD | 226 | Q9Y574 | |
| ALCHRILMTYSVQDH | 751 | Q9UIG0 | |
| IEHPYHTHICRGAMF | 146 | Q8N865 | |
| NHSFMCLIKYGHLRV | 211 | P33681 | |
| MYSRSIQGHHVCLLV | 1106 | O14617 | |
| YSRCLELMLTHVARH | 411 | Q9UF12 | |
| THCRLHTPMYIFLGN | 51 | Q8NHB8 | |
| MAHVRHFRTLVSGFY | 1 | O75311 | |
| TVHHECGRNMYLTGL | 111 | P20702 | |
| EHHSILCSILYAVMR | 1156 | Q9H2M9 | |
| VMTHTYCEHMGIARL | 176 | Q9H346 | |
| SFHRVSLHYGIMCLK | 1001 | O75145 | |
| TCEGMLERIHAYIQH | 626 | Q3V5L5 | |
| YIPLMEFSCSHSHLV | 896 | Q63HM2 | |
| HSVHVCTRCMKGYFI | 996 | Q92824 | |
| YFVQLCSALEHMHSR | 141 | Q8TDX7 | |
| VMFAYEQCLLVLGHH | 276 | Q12996 | |
| TSYLPSEIMLHHCFA | 286 | O60928 | |
| CFYLAEISMALGHLH | 196 | P23443 | |
| VLCYLHDLGIMHRDV | 216 | Q96LW2 | |
| LHVADGLRYLHSAMI | 1976 | Q5S007 | |
| IPFREHCYSFHMELL | 1271 | Q9UBG0 | |
| CELIRHDVFSHNMYT | 601 | Q93074 | |
| HCRVLFLDHVMYTIH | 466 | Q13422 | |
| VIYLFLTVGFMRHHT | 201 | O94886 | |
| LVHFYLVMHLGLTSE | 1036 | Q2PPJ7 | |
| CRVLFLDHVMYTIHM | 476 | Q9UKS7 | |
| FLVLGMRVYHVHSDS | 176 | Q8NFU5 | |
| ICNPFHYITIMSHRC | 176 | Q8NH94 | |
| HYITIMSHRCCVLLL | 181 | Q8NH94 | |
| QRYLLHGLECVVAMH | 311 | P55010 | |
| RMEFTRILCSHEHYV | 1041 | Q96HP0 | |
| FHFHTRSDVRLYGMI | 611 | Q86TI2 | |
| HTYCIRFVPAEMGTH | 2196 | P21333 | |
| HTCLMISCYKGHREI | 151 | Q9BSK4 | |
| VRGCHRHLCYLAELM | 686 | Q86UW7 | |
| CISVTRYMAIAHHRF | 116 | Q9NS66 | |
| VHLAMVRYHEGGRFC | 526 | O00418 | |
| NGGYIFTCRHVVHLM | 481 | Q6SJ93 | |
| HCRVLFLDYVMFTIH | 456 | Q9UKT9 | |
| MSDYLRILEHAIHFG | 3421 | Q9P225 | |
| AGVLHMLYCVLFHGT | 1181 | Q9BY12 | |
| CLRHGFMLHTKYQVV | 211 | Q66K64 | |
| QIARGMHYLHCEALV | 221 | Q16584 | |
| FISYMRHIHRSGPII | 2391 | Q12923 | |
| MPVHYGCKERHFVTI | 191 | P12694 | |
| HPLHYDVIMDRSTCV | 126 | Q8NHC5 | |
| SCGRVLFAVYHMHSK | 216 | Q8N349 | |
| HAHEIGYIVCLIQMF | 106 | Q8NGH7 | |
| HYATIMSRDHCIGLT | 131 | Q8NGI6 | |
| LHQYFHICFVSGMRI | 381 | P33527 | |
| RHGMHVPTFRVQDYC | 341 | Q9Y6P5 | |
| ILVDPYMHEVTHFCL | 256 | Q6P1X5 | |
| CDLYAHHSTARIVMP | 21 | P32249 | |
| LGRIMYTVFEHTFHV | 581 | P41250 | |
| MFLHYYSDRSGLCHI | 51 | O75343 | |
| GLMITSAAIYHVLHF | 91 | P46977 | |
| TIHLMHDGFICTIRY | 2001 | Q9UKZ4 | |
| VSGHQLTHGLLCYEM | 931 | Q8TF17 | |
| LCYEMALLFGLRHRH | 941 | Q8TF17 | |
| MADEIIVFSCGHLYH | 1271 | Q8N3P4 | |
| YLHHSPVGTRVMCDS | 191 | Q9H5K3 | |
| HYPTIMSHGLCFRLA | 131 | O95007 | |
| ALYRHLGTLLRHCVM | 246 | Q9NPQ8 | |
| FRSLAHYHVAMALCD | 351 | Q8TCX5 | |
| CLYVHMFLLARSHTR | 191 | Q01718 | |
| VPHIGECLREMYTTH | 326 | Q70JA7 | |
| AGYSYLICDHMRAVH | 251 | Q53H76 | |
| LICDHMRAVHLYISA | 256 | Q53H76 | |
| YIHMHLFISFILRAA | 176 | P32241 | |
| HLGFLDTLSRVYHML | 681 | Q96KV7 | |
| RDFLTHFYNIMHCGL | 1166 | Q6GYQ0 | |
| YIHMHLFVSFILRAL | 176 | P47872 | |
| DSYLTHCFLQHLMVV | 1261 | Q9Y2I1 | |
| SLTYHREGETLMHEC | 61 | P16471 | |
| CHHVMIEAVGYLYRS | 1061 | Q6P2S7 | |
| GCVYLERMHFIHRDL | 2066 | P08922 | |
| MHGRAYLLLHRDFCD | 1 | Q5VVX9 | |
| EMAFRYHCQLIEHSR | 451 | O75290 | |
| CYSSALRIHQRVHMG | 186 | Q9UK10 | |
| TMVHQAIHTIEYCLG | 716 | Q93050 | |
| ILLAMFLVHYGHRCL | 86 | P18405 | |
| FRGHAICVYHMSSIR | 336 | O15041 | |
| HMRHGSILACAEVAY | 616 | Q9BTW9 | |
| HGCRLLTDMYNAHLT | 111 | O95900 | |
| CYISALRIHQRVHMG | 186 | Q9NZL3 | |
| KGFICRRDLYTHHMV | 351 | Q9NZL3 | |
| ECFLGSIHRDHRYRM | 126 | Q8IWV8 | |
| MHQRIHTGERSYICT | 431 | P51508 | |
| ALHHFMGTCTYVLTR | 1556 | Q9Y493 | |
| DVGTSCLMRHLYRRH | 491 | O75132 | |
| IHGIYIHVFVFLGCM | 1131 | Q8IZF0 |